Return to study ST001098 main page
MB Sample ID: SA074963
| Local Sample ID: | V003 |
| Subject ID: | SU001142 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Age Or Age Range: | 30-60 years old |
| Weight Or Weight Range: | 52.3-176.6 kg |
| Gender: | Male and female |
| Human Medications: | To be included in the study all participants had to be taking an atypical (second-generation) antipsychotic |
| Human Inclusion Criteria: | DSM IV diagnosis of a schizophrenia spectrum diagnosis who had been taking an atypical antipsychotic for at least 6 months, with no changes in antipsychotic regimen for 8 weeks preceding the baseline visit. Twenty age and sex matched obese and nonobese participants without mental health diagnoses were included to match the BMI range of the patients with schizophrenia as BMI controls. |
| Human Exclusion Criteria: | Current use of insulin, diagnosis of diabetes mellitus type 2 prior to antipsychotic exposure, active substance abuse diagnosis |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN001786 |
|---|---|
| Analysis type | MS |
| Chromatography type | GC |
| Chromatography system | Agilent 6890N |
| Column | Unspecified |
| MS Type | Other |
| MS instrument type | |
| MS instrument name | |
| Ion Mode | UNSPECIFIED |
| Units | nmol |
MS:
| MS ID: | MS001649 |
| Analysis ID: | AN001786 |
| MS Type: | Other |
| Ion Mode: | UNSPECIFIED |
